At least 250 lawsuits involving Johnson & Johnson’s improper marketing of Risperdal are pending in Pennsylvania’s Philadelphia Court of Common Pleas, according to information provided by a law firm involved in the litigation. The firm, which represents individuals who may have developed gynecomastia (male breast growth) as a result of the drug, alleges that the unapproved use of Risperdal to treat ADHD is also on the rise.
Further reading:
Antipsychotic Risperdal Slapped with $2 Billion Dementia Penalty (Alzheimer’s & Dementia Weekly)
When is NAMI going to admit marketing Risperdal to children and teens ?
The evidence is on the web archive, this was on the NAMI or “National Alliance on Mental Illness” home page.
“Risperidone for Adolescent Aggression”
Medical Focus, Winter 1996
http://web.archive.org/web/19961221104126/http://www.nami.org/
Is Risperdal FDA approved for angry teens ?
That new ADHD drug Vyvance has to be adding to the number of kids being given nueroleptics for ADHD cause of the awful crash and insomnia it causes with its so called ‘long acting’ formula.
Read the ADD/ADHD forums, no one reports the 12-14 hour “effectiveness” those fraudsters that make the stuff advertise.
I have no problem writing this, I taken Vyvance myself, its awful and anything but new and improved.
Report comment